Other
Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation
Vertex Pharmaceuticals Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation remained flat by 0.0% to $125.00K in Q4 2024 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ4 2024Feb 13, 2026
How to read this metric
A decrease suggests that currency movements have favorably impacted the reporting of tax liabilities, though it does not necessarily imply a change in tax risk.
Detailed definition
This metric quantifies the reduction in the total unrecognized tax benefit liability specifically attributable to the ef...
Peer comparison
Reported by global firms to reconcile changes in tax reserves due to non-operational factors.
Metric ID:
other_unrecognized_tax_benefits_decreases_resulting_from_46aea7Historical Data
1 years
| FY'24 | |
|---|---|
| Value | $500.00K |
Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's unrecognized tax benefits, decrease resulting from foreign currency translation?
- Vertex Pharmaceuticals (VRTX) reported unrecognized tax benefits, decrease resulting from foreign currency translation of $125.00K in Q4 2024.
- What does unrecognized tax benefits, decrease resulting from foreign currency translation mean?
- The reduction in tax contingency reserves caused by foreign currency translation effects.